Author | Nadine M. Tung, MD | OncLive

Author | Nadine M. Tung, MD


Dr. Tung Discusses the Role of Olaparib in Breast Cancer

March 30, 2018


Nadine M. Tung, MD, associate professor of medicine, Harvard Medical School, director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Center, discusses the role of olaparib (Lynparza) in the treatment of patients with breast cancer.